• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞内脂质积累对非酒精性脂肪性肝病新模型的影响。

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.

机构信息

Fondazione Italiana Fegato- Centro Studi Fegato, AREA SCIENCE Park Basovizza, Bldg Q, Trieste, Italy.

出版信息

BMC Gastroenterol. 2012 Mar 1;12:20. doi: 10.1186/1471-230X-12-20.

DOI:10.1186/1471-230X-12-20
PMID:22380754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3313845/
Abstract

BACKGROUND

In vitro exposure of liver cells to high concentrations of free fatty acids (FFA) results in fat overload which promotes inflammatory and fibrogenic response similar to those observed in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Since the mechanisms of this event have not been fully characterized, we aimed to analyze the fibrogenic stimuli in a new in vitro model of NASH.

METHODS

HuH7 cells were cultured for 24 h in an enriched medium containing bovine serum albumin and increasing concentrations of palmitic and oleic acid at a molar ratio of 1:2 (palmitic and oleic acid, respectively). Cytotoxic effect, apoptosis, oxidative stress, and production of inflammatory and fibrogenic cytokines were measured.

RESULTS

FFA induces a significant increment in the intracellular content of lipid droplets. The gene expression of interleukin-6, interleukin-8 and tumor necrosis factor alpha was significantly increased. The protein level of interleukin-8 was also increased. Intracellular lipid accumulation was associated to a significant up-regulation in the gene expression of transforming growth factor beta 1, alpha 2 macroglobulin, vascular endothelial growth factor A, connective tissue growth factor, insulin-like growth factor 2, thrombospondin 1. Flow cytometry analysis demonstrated a significant increment of early apoptosis and production of reactive oxygen species.

CONCLUSIONS

The exposure of hepatocytes to fatty acids elicits inflammation, increase of oxidative stress, apoptosis and production of fibrogenic cytokines. These data support a primary role of FFA in the pathogenesis of NAFLD and NASH.

摘要

背景

体外培养的肝细胞暴露于高浓度游离脂肪酸(FFA)会导致脂肪过载,从而促进炎症和纤维化反应,类似于非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)患者中观察到的反应。由于尚未完全阐明这种情况的机制,我们旨在分析新的 NASH 体外模型中的纤维生成刺激物。

方法

HuH7 细胞在含有牛血清白蛋白和不同浓度棕榈酸和油酸(摩尔比为 1:2)的丰富培养基中培养 24 小时。测量细胞毒性、细胞凋亡、氧化应激以及炎症和纤维化细胞因子的产生。

结果

FFA 诱导细胞内脂滴含量显著增加。白细胞介素 6、白细胞介素 8 和肿瘤坏死因子-α的基因表达显著增加。白细胞介素 8 的蛋白水平也增加。细胞内脂质积累与转化生长因子-β 1、α 2 巨球蛋白、血管内皮生长因子 A、结缔组织生长因子、胰岛素样生长因子 2、血小板反应蛋白 1 的基因表达显著上调相关。流式细胞术分析表明早期凋亡和活性氧产生显著增加。

结论

肝细胞暴露于脂肪酸会引发炎症、氧化应激增加、细胞凋亡和纤维生成细胞因子的产生。这些数据支持 FFA 在 NAFLD 和 NASH 发病机制中的主要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/0244781ff095/1471-230X-12-20-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/322c85489b24/1471-230X-12-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/02c5d61175e2/1471-230X-12-20-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/3032e007e289/1471-230X-12-20-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/3a7f4326603f/1471-230X-12-20-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/0244781ff095/1471-230X-12-20-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/322c85489b24/1471-230X-12-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/02c5d61175e2/1471-230X-12-20-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/3032e007e289/1471-230X-12-20-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/3a7f4326603f/1471-230X-12-20-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eebd/3313845/0244781ff095/1471-230X-12-20-5.jpg

相似文献

1
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.细胞内脂质积累对非酒精性脂肪性肝病新模型的影响。
BMC Gastroenterol. 2012 Mar 1;12:20. doi: 10.1186/1471-230X-12-20.
2
A human hepatocellular in vitro model to investigate steatosis.一种用于研究脂肪变性的人肝细胞体外模型。
Chem Biol Interact. 2007 Jan 30;165(2):106-16. doi: 10.1016/j.cbi.2006.11.004. Epub 2006 Nov 23.
3
The role of hepassocin in the development of non-alcoholic fatty liver disease.海帕西菌素在非酒精性脂肪性肝病发展中的作用。
J Hepatol. 2013 Nov;59(5):1065-72. doi: 10.1016/j.jhep.2013.06.004. Epub 2013 Jun 18.
4
Cellular glutathione in fatty liver in vitro models.细胞内谷胱甘肽在体外脂肪性肝病模型中的作用。
Toxicol In Vitro. 2011 Oct;25(7):1501-6. doi: 10.1016/j.tiv.2011.05.011. Epub 2011 May 17.
5
Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.烟酸抑制培养肝细胞中的脂肪积累、氧化应激和炎性细胞因子白细胞介素-8:对非酒精性脂肪性肝病的影响。
Metabolism. 2015 Sep;64(9):982-90. doi: 10.1016/j.metabol.2015.05.002. Epub 2015 May 7.
6
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes.游离脂肪酸在肝细胞中蓄积诱导炎症反应的动力学。
Ann Hepatol. 2013;13(1):113-20.
7
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.油酸和棕榈酸对培养肝细胞脂质积累和凋亡的差异作用。
J Gastroenterol Hepatol. 2009 May;24(5):830-40. doi: 10.1111/j.1440-1746.2008.05733.x. Epub 2009 Jan 13.
8
Protective effect of the Y220C mutant p53 against steatosis: good news?Y220C 突变型 p53 对脂肪变性的保护作用:好消息?
J Cell Physiol. 2014 Sep;229(9):1182-92. doi: 10.1002/jcp.24550.
9
Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.细胞和线粒体高脂高糖毒性对人 HepG2 细胞的探索性数据分析。
Nutrients. 2021 May 19;13(5):1723. doi: 10.3390/nu13051723.
10
Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.肝细胞暴露于颗粒中时脂质和氧化损伤 DNA 的积累。
Toxicol Appl Pharmacol. 2014 Jan 15;274(2):350-60. doi: 10.1016/j.taap.2013.10.001. Epub 2013 Oct 11.

引用本文的文献

1
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity.脂肪细胞衍生的细胞外囊泡的分泌增加与人类肥胖症中脂肪组织的炎症和多余脂质的动员有关。
J Transl Med. 2024 Jul 4;22(1):623. doi: 10.1186/s12967-024-05249-w.
2
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.成纤维细胞生长因子 21 是一种参与 MASLD 进展的肝分泌因子。
United European Gastroenterol J. 2024 Oct;12(8):1056-1068. doi: 10.1002/ueg2.12534. Epub 2024 Jun 18.
3
The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies.

本文引用的文献

1
Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2.维生素D可改善肝星状细胞系LX-2中游离脂肪酸引发的应激配体表达。
Turk J Gastroenterol. 2011 Aug;22(4):400-7. doi: 10.4318/tjg.2011.0254.
2
Mechanisms of lipotoxicity in NAFLD and clinical implications.非酒精性脂肪性肝病中脂毒性的机制及临床意义。
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):131-40. doi: 10.1097/MPG.0b013e31822578db.
3
Cellular glutathione in fatty liver in vitro models.细胞内谷胱甘肽在体外脂肪性肝病模型中的作用。
网膜素-1 在肥胖相关代谢功能障碍相关脂肪性肝病中的潜在作用:来自转化研究的证据。
J Transl Med. 2023 Dec 11;21(1):906. doi: 10.1186/s12967-023-04770-8.
4
Targeting dysregulated lipid metabolism in the tumor microenvironment.靶向肿瘤微环境中失调的脂质代谢。
Arch Pharm Res. 2023 Dec;46(11-12):855-881. doi: 10.1007/s12272-023-01473-y. Epub 2023 Dec 7.
5
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma.肝脏疾病中的性别差异:临床前模型如何有助于剖析维持非酒精性脂肪性肝病和肝细胞癌的性别相关机制。
iScience. 2023 Oct 30;26(12):108363. doi: 10.1016/j.isci.2023.108363. eCollection 2023 Dec 15.
6
Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression.法尼基转移酶抑制剂通过抑制炎症和缺氧诱导因子-1α表达抑制 NASH 相关 HCC。
Int J Mol Sci. 2023 Jul 17;24(14):11546. doi: 10.3390/ijms241411546.
7
Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma.BMP 和 Activin 膜结合抑制剂(BAMBI)在慢性肝病和肝细胞癌中的表达和功能。
Int J Mol Sci. 2023 Feb 9;24(4):3473. doi: 10.3390/ijms24043473.
8
Regulation of lipid droplet (LD) formation in hepatocytes regulation of SREBP1c by non-coding RNAs.肝细胞中脂滴(LD)形成的调控:非编码RNA对SREBP1c的调控
Front Med (Lausanne). 2022 Sep 20;9:903856. doi: 10.3389/fmed.2022.903856. eCollection 2022.
9
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.miR-22 缺失促进脂肪肝中的肝细胞癌发展。
Cells. 2022 Sep 14;11(18):2860. doi: 10.3390/cells11182860.
10
Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease.三维类器官作为研究非酒精性脂肪性肝病的模型。
Semin Liver Dis. 2022 Nov;42(4):423-433. doi: 10.1055/a-1934-5588. Epub 2022 Aug 31.
Toxicol In Vitro. 2011 Oct;25(7):1501-6. doi: 10.1016/j.tiv.2011.05.011. Epub 2011 May 17.
4
In vitro models for the study of non-alcoholic fatty liver disease.用于研究非酒精性脂肪性肝病的体外模型。
Curr Med Chem. 2011;18(7):1079-84. doi: 10.2174/092986711794940842.
5
Fatty liver and lipotoxicity.脂肪肝与脂毒性
Biochim Biophys Acta. 2010 Mar;1801(3):299-310. doi: 10.1016/j.bbalip.2009.10.007. Epub 2009 Oct 24.
6
Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro.体外肝血窦内皮细胞表型的微环境调节
Hepatology. 2009 Sep;50(3):920-8. doi: 10.1002/hep.23085.
7
Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.不饱和脂肪酸通过下调肿瘤抑制因子PTEN来促进肝癌的增殖和进展。
J Hepatol. 2009 Jun;50(6):1132-41. doi: 10.1016/j.jhep.2009.01.027. Epub 2009 Apr 1.
8
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.白藜芦醇增强游离脂肪酸对人肝星状细胞的促纤维化作用。
Hepatol Res. 2009 Jun;39(6):601-8. doi: 10.1111/j.1872-034X.2008.00485.x. Epub 2009 Jan 14.
9
Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat.肝刺激物质在大鼠实验性诱导纤维化和肝硬化中的作用。
Dig Dis Sci. 2009 Nov;54(11):2367-76. doi: 10.1007/s10620-008-0623-1. Epub 2008 Dec 10.
10
Liver and heart: a new link?肝脏与心脏:一种新的关联?
J Hepatol. 2008 Aug;49(2):300-2. doi: 10.1016/j.jhep.2008.05.003. Epub 2008 May 22.